Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity (Adv. Therap. 7/2021)
Advanced Therapeutics
; 4(7):2170016, 2021.
Article
in English
| Wiley | ID: covidwho-1323847
ABSTRACT
SARS-CoV-2 infects human cells by binding its spike protein to the human ACE2 receptor. Using a peptide biopanning strategy, the authors have discovered small anti-ACE2 peptides that can effectively block the SARS-CoV-2/ACE2 interaction. The anti-ACE2 peptides can be potentially used as prophylactic or therapeutic agents for SARS-CoV-2 and other ACE2-mediated viruses. This is reported by Kun Cheng and co-workers in article number 2100087.
Full text:
Available
Collection:
Databases of international organizations
Database:
Wiley
Language:
English
Journal:
Advanced Therapeutics
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS